Sanara MedTech Inc. filed a Form 8-K on October 29, 2026, disclosing the October 6, 2026 sale of all assets of its wholly owned subsidiary Tissue Health Plus, LLC to an unrelated third party for approximately $2,000,000, plus certain earnout rights.

Key Highlights

  • Asset sale completed: Sanara MedTech sold all assets of Tissue Health Plus, LLC, a wholly owned subsidiary, on October 6, 2026.
  • Purchase price: The transaction carried a purchase price of approximately $2,000,000, according to the filing.
  • Assets transferred: The sale included THP's business software products and related intellectual property.
  • Earnout rights retained: The company disclosed it received certain earnout rights in connection with the transaction.
  • Buyer: The purchaser was described in the filing as an unrelated third party.
  • Signed by CFO: The filing was signed by Elizabeth B. Taylor, Chief Financial Officer of Sanara MedTech Inc.

Sanara MedTech Divests Tissue Health Plus Subsidiary in October 2026

Sanara MedTech Inc. (NASDAQ:SMTI), a Texas-based company headquartered at 1200 Summit Avenue, Suite 414, Fort Worth, Texas 76102, disclosed under Item 7.01 (Regulation FD Disclosure) that it completed the sale of all assets belonging to Tissue Health Plus, LLC on October 6, 2026. According to the filing, THP was a wholly owned subsidiary of the company prior to the transaction.

The filing states that the assets sold included THP's business software products and related intellectual property. The purchase price was reported as approximately $2,000,000, paid by an unrelated third party. In addition to the upfront consideration, the company disclosed that it received certain earnout rights, though no further details regarding the structure or potential value of those earnout rights were provided in the filing.

The disclosure was made pursuant to Regulation FD and was reported on October 29, 2026, with an event date of October 6, 2026. Chief Financial Officer Elizabeth B. Taylor signed the filing on behalf of Sanara MedTech Inc.

What Was Disclosed

Sanara MedTech reported the completed divestiture of Tissue Health Plus, LLC's assets, including business software products and intellectual property, for approximately $2,000,000 plus certain earnout rights, to an unrelated third party on October 6, 2026.